Pricing Log in Create free account

Electromed, Inc. (ELMD) vs RxSight, Inc. (RXST)

Electromed, Inc. and RxSight, Inc. are both Medical Devices companies. Electromed, Inc. is the larger, with a market value of $221.8M against $190.4M — 1.2× the size. RxSight, Inc. has negative trailing earnings, so its P/E is not meaningful; Electromed, Inc. trades at 19.4×. Electromed, Inc. grew revenue faster over the last twelve months: 15.3% against −14.3%. Electromed, Inc. has the higher net margin (15.3% vs −43.8%) and the higher return on invested capital (25.9% vs −16,845.7%). Across the 20 metrics below, Electromed, Inc. leads on 12 and RxSight, Inc. on 8.

Valuation

Metric ELMD RXST Medical Devices median
P/E 19.39 n/m 25.58
P/S 2.98 1.52 2.54
P/B 4.07 0.72 2.48
Price to free cash flow 26.26 9.91 28.81
EV/EBITDA 13.39 0.77 11.51
EV/Sales 2.72 (0.41) 2.72
Earnings yield 5.16% (28.87%) (12.82%)
Free cash flow yield 3.81% 10.09% (8.18%)

Profitability

Metric ELMD RXST Medical Devices median
Gross margin 78.54% 76.13% 57.76%
Operating margin 18.82% (50.44%) (15.07%)
Net margin 15.32% (43.80%) (14.45%)
Free cash flow margin 11.34% 15.30% (3.88%)
Return on equity 23.26% (20.10%) (10.35%)
Return on assets 18.82% (16.44%) (17.26%)
Return on invested capital 25.87% (16,845.67%) (5.27%)

Growth

Metric ELMD RXST Medical Devices median
Revenue growth (TTM) 15.28% (14.26%) 10.41%
EPS growth (last fiscal year) 52.94% (33.80%) 28.17%
Revenue growth, 5-year CAGR 15.59% 55.74% 15.74%
Net income growth, 5-year CAGR 36.76% 0.00% 0.00%

Health

Metric ELMD RXST Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 4.69 4.20 2.74
Net debt to EBITDA (1.37) 4.27 0.54

Dividend

Metric ELMD RXST Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric ELMD RXST Medical Devices median
Market cap 221.84m 190.36m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack